Bringing the fundamentals into focus…
Back to ARS Pharmaceuticals, Inc.
How ARS Pharmaceuticals, Inc. stacks up
SPRY · against 319 other Healthcare companies of similar size
Growth
85/ 100
Near the top of its peers.
Ranked #40 of 320 · scores higher than 86% of peers
Bars: peers in each 10-point band of the growth score21 peers with a growth score of 80–89, including SPRY · Click a bar to see the companies
Why growth scores 85?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 4.1% vs peer median 6.1%
- faster revenue growth over three years: stronger than 100% of peers. 3-year revenue growth: 711.3% vs peer median 5.8%
Metric by metric
Position: dot = SPRY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SPRY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 332 reported | 4.1% | 3.0% | 54% | 33% | |
| Earnings per share growthHigher is better · 147 reported | Not reported | 2.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 311 reported | 711.3% | 3.7% | 100% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around SPRY| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 592M ILS (≈$160M) | 99 | 84 | |
| 2 | 433M USD | 99 | 81 | |
| 40 | 3.4B CNY (≈$478M) | 85 | 77 | |
| 40 | 2.4B CNY (≈$331M) | 85 | 51 | |
| 40 | 393M USD | 85 | 50 | |
| 40 | 5.1B MXN (≈$274M) | 85 | 48 | |
| 40 | 303M USD | 85 | 27 | |
| 40 | 513M USD | 85 | 31 | |
| 46 | 672.6B KRW (≈$484M) | 84 | 69 | |
| 46 | 222M USD | 84 | 31 | |
| 46 | 399M USD | 84 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score